Companies: 10,795·Total market cap: $144.5T
CureVac N.V.

CureVac N.V.

CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio
52W High$5.72
52W Low$2.475
Overview

CureVac N.V. (CVAC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CVAC · as of Apr 11, 2025

Latest filing snapshot

983
-189-16.13%vs prior year

CureVac N.V. (CVAC) employee data is sourced from the annual SEC 20-F filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing

SEC 20-F·Period end: 2024-12-31·Full-time · Global
Total Employees
983
Change (1Y)
-189
Growth % (1Y)
-16.13%
Revenue / Employee
$544.4K
Net Income / Employee
$165.0K
Market Cap
$1.0B

CVAC Employee Count

2020 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-04-11983-189-16.13%
2024-04-251,172+123+11.73%
2023-04-251,049+401+61.88%
2022-04-28648+94+16.97%
2021-04-27554

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
CureVac N.V.
CVAC
CureVac N.V.YOU
983
#2
Novavax, Inc.
NVAX
Novavax, Inc.
952
#3
Immatics N.V.
IMTX
Immatics N.V.
554
#4
Inhibrx Biosciences, Inc.
INBX
Inhibrx Biosciences, Inc.
156
#5
Amylyx Pharmaceuticals, Inc.
AMLX
Amylyx Pharmaceuticals, Inc.
123
#6
Enliven Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
62
#7
Nektar Therapeutics
NKTR
Nektar Therapeutics
61
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CVAC peer comparison

About CVAC employees

CVAC Employees · Headcount

CureVac N.V. (CVAC) employee data is sourced from the annual SEC 20-F filing. As of 2024, CureVac N.V. had 983 full-time employees globally. Full-time employees only. Global consolidated headcount.

CureVac N.V. employs 983 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $544,435, reflecting the company's operational efficiency.

CureVac N.V.'s workforce decreased by 189 (16.13%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

CureVac N.V.'s revenue per employee of $544,435 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

CVAC Employees · 5 questions

As of the latest SEC 20-F filing (2024), CureVac N.V. had 983 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

CureVac N.V. employee counthow many employees does CureVac N.V. haveCVAC total employees 2024

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-04-11